• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PC12细胞中腺苷A2受体的药理学特性

Pharmacological profile of adenosine A2 receptor in PC12 cells.

作者信息

Noronha-Blob L, Marshall R P, Kinnier W J, U'Prichard D C

出版信息

Life Sci. 1986 Sep 22;39(12):1059-67. doi: 10.1016/0024-3205(86)90197-9.

DOI:10.1016/0024-3205(86)90197-9
PMID:3018408
Abstract

The PC12 cell line, a clone isolated from a pheochromocytoma tumor of rat adrenal medulla, was shown to exclusively contain stimulatory adenosine (A2) receptors linked to adenylate cyclase (AC). AC was stimulated 6-7 fold by several agonists with a rank order of potency of 5'-N-Ethyl carboxamidoadenosine (NECA) greater than 2-Chloroadenosine (2-CADO) greater than (R)-N-Phenylisopropyladenosine (R-(-)-PIA) greater than N6-Cyclopentyladenosine (CPA) greater than N6-Cyclohexyladenosine (CHA) greater than S-(+)-PIA. AC activity was antagonized by a variety of adenosine receptor antagonists with a potency order of 1,3,-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine (PACPX) greater than 1,3,-Diethyl-8-phenylxanthine (DPX) greater than 8-Phenyltheophylline greater than 3-Isobutyl-1-methylxanthine (IBMX) greater than 8-(p-sulfophenyl)theophylline (PST) greater than 7-(beta-chloroethyl)theophylline greater than theophylline = enprofylline = caffeine. Under conditions known to favour receptor-mediated Ni-coupled inhibition of AC, R-(-)-PIA failed to inhibit both basal and forskolin stimulated AC activity in PC12 cells, confirming the absence of an A1 mediated response. On the other hand, adenosine agonists inhibited AC activity in rat cortical membranes with a rank order of potency of CPA greater than R-(-)-PIA greater than CHA greater than NECA greater than S-(+)-PIA greater than 2-CADO. These findings suggest that PC12 cells are functionally deficient in an A1 receptor linked AC response but are efficiently coupled to A2 stimulatory receptors. The cells should prove useful for further study of A2 adenosine receptors and to establish selectivity profiles of compounds acting at both A1 and A2 receptors.

摘要

PC12细胞系是从大鼠肾上腺髓质嗜铬细胞瘤中分离出的一个克隆,已证明其仅含有与腺苷酸环化酶(AC)相连的刺激性腺苷(A2)受体。几种激动剂可使AC活性增强6至7倍,其效力顺序为5'-N-乙基羧酰胺基腺苷(NECA)>2-氯腺苷(2-CADO)>(R)-N-苯基异丙基腺苷(R-(-)-PIA)>N6-环戊基腺苷(CPA)>N6-环己基腺苷(CHA)>S-(+)-PIA。AC活性受到多种腺苷受体拮抗剂的拮抗,其效力顺序为1,3-二丙基-8-(2-氨基-4-氯苯基)黄嘌呤(PACPX)>1,3-二乙基-8-苯基黄嘌呤(DPX)>8-苯基茶碱>3-异丁基-1-甲基黄嘌呤(IBMX)>8-(对磺基苯基)茶碱(PST)>7-(β-氯乙基)茶碱>茶碱 = 恩丙茶碱 = 咖啡因。在已知有利于受体介导的Ni偶联抑制AC的条件下,R-(-)-PIA未能抑制PC12细胞中的基础AC活性和福斯高林刺激的AC活性,证实不存在A1介导的反应。另一方面,腺苷激动剂抑制大鼠皮质膜中的AC活性,其效力顺序为CPA>R-(-)-PIA>CHA>NECA>S-(+)-PIA>2-CADO。这些发现表明,PC12细胞在与A1受体相连的AC反应中功能缺陷,但能有效地与A2刺激性受体偶联。这些细胞应有助于进一步研究A2腺苷受体,并建立作用于A1和A2受体的化合物的选择性概况。

相似文献

1
Pharmacological profile of adenosine A2 receptor in PC12 cells.PC12细胞中腺苷A2受体的药理学特性
Life Sci. 1986 Sep 22;39(12):1059-67. doi: 10.1016/0024-3205(86)90197-9.
2
Characterization of adenosine receptors in the PC12 pheochromocytoma cell line using radioligand binding: evidence for A-2 selectivity.
J Neurochem. 1987 Feb;48(2):498-502. doi: 10.1111/j.1471-4159.1987.tb04120.x.
3
Effect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slices.腺苷受体激动剂及其他化合物对福斯高林处理的海马切片中环磷酸腺苷积累的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):173-8. doi: 10.1007/BF00511409.
4
Classification of adenosine receptors mediating antinociception in the rat spinal cord.介导大鼠脊髓中抗伤害感受的腺苷受体分类。
Br J Pharmacol. 1986 Aug;88(4):923-30. doi: 10.1111/j.1476-5381.1986.tb16267.x.
5
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.用[3H]NECA标记的大鼠纹状体膜中A2腺苷受体的特性研究。
Mol Pharmacol. 1986 Apr;29(4):331-46.
6
Labelling of Ri adenosine receptors in rat fat cell membranes with (-)-[125iodo]N6-hydroxyphenylisopropyladenosine.用(-)-[125碘]N6-羟基苯异丙基腺苷对大鼠脂肪细胞膜中的Ri腺苷受体进行标记。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(3):233-40. doi: 10.1007/BF00505324.
7
Adenosine receptor-mediated contraction and relaxation of guinea-pig isolated tracheal smooth muscle: effects of adenosine antagonists.腺苷受体介导的豚鼠离体气管平滑肌收缩与舒张:腺苷拮抗剂的作用
Br J Pharmacol. 1988 Oct;95(2):371-8. doi: 10.1111/j.1476-5381.1988.tb11655.x.
8
A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.豚鼠大脑皮层中A1腺苷受体对环磷酸腺苷形成及放射性配体结合的抑制作用。
Br J Pharmacol. 1994 Dec;113(4):1501-7. doi: 10.1111/j.1476-5381.1994.tb17166.x.
9
A selective binding site for 3H-NECA that is not an adenosine A2 receptor.一个并非腺苷A2受体的3H-NECA选择性结合位点。
Biochem Pharmacol. 1989 Nov 1;38(21):3827-33. doi: 10.1016/0006-2952(89)90592-3.
10
Autoradiographic characterization of high-affinity adenosine A2 receptors in the rat brain.大鼠脑中高亲和力腺苷A2受体的放射自显影表征
Brain Res. 1989 Apr 10;484(1-2):111-8. doi: 10.1016/0006-8993(89)90353-3.

引用本文的文献

1
Endogenous expression of adenosine A1, A2 and A3 receptors in rat C6 glioma cells.大鼠C6胶质瘤细胞中腺苷A1、A2和A3受体的内源性表达。
Neurochem Res. 2007 Jun;32(6):1056-70. doi: 10.1007/s11064-006-9273-x. Epub 2007 Mar 31.
2
Direct interaction of adenosine with the TRPV1 channel protein.腺苷与TRPV1通道蛋白的直接相互作用。
J Neurosci. 2004 Apr 7;24(14):3663-71. doi: 10.1523/JNEUROSCI.4773-03.2004.
3
Regulation of the differentiation of PC12 pheochromocytoma cells.PC12嗜铬细胞瘤细胞分化的调控
Environ Health Perspect. 1989 Mar;80:127-42. doi: 10.1289/ehp.8980127.
4
Characterization of diadenosine tetraphosphate (Ap4A) binding sites in cultured chromaffin cells: evidence for a P2y site.培养的嗜铬细胞中二磷酸腺苷四磷酸(Ap4A)结合位点的表征:P2y位点的证据。
Br J Pharmacol. 1991 Aug;103(4):1980-4. doi: 10.1111/j.1476-5381.1991.tb12363.x.
5
A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.来自大鼠纹状体和大鼠嗜铬细胞瘤PC12细胞的A2A腺苷受体:通过放射性配体结合和腺苷酸环化酶激活进行表征。
Mol Pharmacol. 1992 Feb;41(2):352-9.